Rnai-mediated inhibition of igf1r for treatment of ocular...

Details Rnai-mediated inhibition of igf1r for treatment of ocular... Rnai-mediated inhibition of igf1r for treatment of ocular...

A - Human Necessities

61

K

A61K 31/713 (2006.01) A61K 31/7088 (2006.01) A61K 48/00 (2006.01) A61P 27/02 (2006.01) C12N 15/63 (2006.01) C12N 15/85 (2006.01) C12N 15/11 (2006.01) C12N 5/06 (2006.01)

Patent

CA 2632690

RNA interference is provided for inhibition of IGFlR mRNA expression for treating patients with ocular angiogenesis, particularly for treating retinal edema, diabetic retinopathy, sequela associated with retinal ischemia, posterior segment neovascularization (PSNV), and neovascular glaucoma, and for treating patients at risk of developing such conditions.

L'ARN interférent est mis en oeuvre pour inhiber l'expression de l'ARNm de IGFlR, en vue de traiter des patients atteints d'angiogenèse oculaire, notamment pour traiter l'oedème rétinien, la rétinopathie diabétique, des séquelles associées à l'ischémie rétinienne, à la néovascularisation du segment postérieur (PSNV), au glaucome néovasculaire, et pour traiter des patients susceptibles de développer ces affections.

Affiliated with

Also associated with

Rating

Rnai-mediated inhibition of igf1r for treatment of ocular... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rnai-mediated inhibition of igf1r for treatment of ocular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rnai-mediated inhibition of igf1r for treatment of ocular... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2000907